1516896-09-5

1516896-09-5 structure

Name: PDE10-IN-1
Chemical Name: Imidazo[2,1-f][1,6]naphthyridine, 2-[(1R,2R)-2-(5,8-dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)cyclopropyl]-3-methyl
CAS Number: 1516896-09-5
Molecular Formula: C₂₁H₁₉N₇
Molecular Weight: 369.422
Catalog: Signaling Pathways Metabolic Enzyme/Protease Phosphodiesterase (PDE)
Create Date: 2017-05-14 16:45:49
Modify Date: 2024-01-07 18:44:55
PDE10-IN-1 is a potent PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1, for treating CNS and metabolic disorders.

Name	Imidazo[2,1-f][1,6]naphthyridine, 2-[(1R,2R)-2-(5,8-dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)cyclopropyl]-3-methyl
Synonyms	Imidazo[2,1-f][1,6]naphthyridine, 2-[(1R,2R)-2-(5,8-dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)cyclopropyl]-3-methyl- 2-[(1R,2R)-2-(5,8-Dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)cyclopropyl]-3-methylimidazo[2,1-f][1,6]naphthyridine PDE10-IN-1

Description	PDE10-IN-1 is a potent PDE10-IN-1 inhibitor extracted from Patent WO 2013192273 A1, for treating CNS and metabolic disorders.
Related Catalog	Signaling Pathways >> Metabolic Enzyme/Protease >> Phosphodiesterase (PDE) Research Areas >> Neurological Disease
References	[1]. Campbell, John Emmerson, et al. Preparation of heteroaryl compounds as PDE-10 inhibitors for treating CNS and metabolic disorders. Patent WO 2013192273 A1 20131227.